US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
DE2010115A1
(de)
|
1970-03-04 |
1971-09-16 |
Farbenfabriken Bayer Ag, 5090 Leverkusen |
Verfahren zur Herstellung von Mikrogranulaten
|
US4389330A
(en)
|
1980-10-06 |
1983-06-21 |
Stolle Research And Development Corporation |
Microencapsulation process
|
US4675189A
(en)
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
US4474572A
(en)
|
1981-09-29 |
1984-10-02 |
Syntex (U.S.A.) Inc. |
Implanting device and implant magazine
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
US4758435A
(en)
|
1986-08-11 |
1988-07-19 |
American Cyanamid Company |
Estradiol implant composition and method for preparation
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
US4900552A
(en)
|
1988-03-30 |
1990-02-13 |
Watson Laboratories, Inc. |
Mucoadhesive buccal dosage forms
|
WO1991008231A1
(en)
|
1989-11-29 |
1991-06-13 |
Brigham And Women's Hospital |
[Ala IL-8]77 AS A LEUKOCYTE ADHESION INHIBITOR
|
US6221367B1
(en)
|
1992-06-15 |
2001-04-24 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5122377A
(en)
*
|
1990-11-19 |
1992-06-16 |
A.H. Robins, Company, Incorporated |
Oral delivery system for veterinary drugs
|
EP0551626A1
(en)
|
1991-12-19 |
1993-07-21 |
LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. |
Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
EP0688429B1
(en)
|
1993-03-09 |
1998-02-11 |
Epic Therapeutics, Inc.. |
Macromolecular microparticles and methods of production
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5421818A
(en)
|
1993-10-18 |
1995-06-06 |
Inner Ear Medical Delivery Systems, Inc. |
Multi-functional inner ear treatment and diagnostic system
|
TW438601B
(en)
|
1994-05-18 |
2001-06-07 |
Janssen Pharmaceutica Nv |
New mucoadhesive emulsion compositions and a process for the preparation thereof
|
WO1996000081A1
(en)
|
1994-06-24 |
1996-01-04 |
Immunex Corporation |
Controlled release polypeptide compositions and methods of treating inflammatory bowel disease
|
GB9505032D0
(en)
|
1995-03-13 |
1995-05-03 |
Westminster Lab Ltd |
Improvements in or relating to organic compositions
|
IL112834A
(en)
|
1995-03-01 |
2000-12-06 |
Yeda Res & Dev |
Pharmaceutical compositions for controlled release of soluble receptors
|
FR2742357B1
(fr)
|
1995-12-19 |
1998-01-09 |
Rhone Poulenc Rorer Sa |
Nanoparticules stabilisees et filtrables dans des conditions steriles
|
US6379911B2
(en)
|
1996-02-23 |
2002-04-30 |
Albert Einstein College Of Medicine Of Yeshiva University |
Enzyme detection/assay method and substrates
|
AU720232B2
(en)
|
1996-07-19 |
2000-05-25 |
Amgen, Inc. |
Analogs of cationic proteins
|
US5945126A
(en)
|
1997-02-13 |
1999-08-31 |
Oakwood Laboratories L.L.C. |
Continuous microsphere process
|
US6045528A
(en)
|
1997-06-13 |
2000-04-04 |
Intraear, Inc. |
Inner ear fluid transfer and diagnostic system
|
US5939421A
(en)
|
1997-07-01 |
1999-08-17 |
Signal Pharmaceuticals, Inc. |
Quinazoline analogs and related compounds and methods for treating inflammatory conditions
|
EP1021204B1
(en)
|
1997-09-26 |
2005-12-28 |
Noven Pharmaceuticals, Inc. |
Bioadhesive compositions and methods for topical administration of active agents
|
US5985848A
(en)
|
1997-10-14 |
1999-11-16 |
Albert Einstein College Of Medicine Of Yeshiva University |
Inhibitors of nucleoside metabolism
|
GB9812426D0
(en)
|
1998-06-10 |
1998-08-05 |
Reckitt & Colmann Prod Ltd |
Improvements in or relating to organic compositions
|
US20020009478A1
(en)
|
1998-08-24 |
2002-01-24 |
Douglas Joseph Dobrozsi |
Oral liquid mucoadhesive compositions
|
US6319513B1
(en)
|
1998-08-24 |
2001-11-20 |
The Procter & Gamble Company |
Oral liquid mucoadhesive compounds
|
US6270802B1
(en)
|
1998-10-28 |
2001-08-07 |
Oakwood Laboratories L.L.C. |
Method and apparatus for formulating microspheres and microcapsules
|
WO2000061783A2
(en)
|
1999-04-08 |
2000-10-19 |
Industrial Research Limited |
Process for preparing inhibitors of nucleoside metabolism
|
ES2312344T3
(es)
|
1999-05-28 |
2009-03-01 |
Targeted Genetics Corporation |
Metodos y composiciones para disminuir el nivel de factor de necrosis tumoral (tnf) en trastornos asociados con tnf.
|
SI1194425T1
(sl)
|
1999-06-23 |
2005-12-31 |
Sanofi Aventis Deutschland |
Substituirani benzimidazoli
|
US6458387B1
(en)
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
DE19951360A1
(de)
|
1999-10-26 |
2001-05-03 |
Aventis Pharma Gmbh |
Substituierte Indole
|
EP1246792B1
(en)
|
2000-01-13 |
2014-08-13 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
GB0003154D0
(en)
|
2000-02-12 |
2000-04-05 |
Astrazeneca Uk Ltd |
Novel compounds
|
WO2001068648A1
(en)
|
2000-03-15 |
2001-09-20 |
Aventis Pharma Deutschland Gmbh |
Substituted beta-carbolines with ikb-kinase inhibiting activity
|
KR100823764B1
(ko)
|
2000-06-22 |
2008-04-21 |
제넨테크, 인크. |
아고니스트 안티-티알케이-씨 모노클로날 항체
|
US20020013331A1
(en)
|
2000-06-26 |
2002-01-31 |
Williams Robert O. |
Methods and compositions for treating pain of the mucous membrane
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
US7109331B2
(en)
|
2000-08-29 |
2006-09-19 |
Industrial Research Limited |
5H-pyrrolo[3,2-d]pyrimidine nucleoside metabolism inhibitors
|
JP4272338B2
(ja)
|
2000-09-22 |
2009-06-03 |
バイエル アクチェンゲゼルシャフト |
ピリジン誘導体
|
JP2004509918A
(ja)
*
|
2000-09-25 |
2004-04-02 |
バイエル・ヘルスケア・エルエルシー |
鼓膜の破れた動物の治療のための耳治療用の抗微生物剤の組み合わせ物
|
AU2002211662A1
(en)
|
2000-10-12 |
2002-04-22 |
Smith Kline Beecham Corporation |
Nf-kappab inhibitors
|
JP2004523476A
(ja)
|
2000-10-12 |
2004-08-05 |
スミスクライン・ビーチャム・コーポレイション |
NF−κB阻害剤
|
IL155519A0
(en)
|
2000-10-26 |
2003-11-23 |
Tularik Inc |
Antiinflammation agents
|
JP2002193938A
(ja)
|
2000-12-01 |
2002-07-10 |
Bayer Ag |
4−アリールピリジン誘導体
|
US7122544B2
(en)
|
2000-12-06 |
2006-10-17 |
Signal Pharmaceuticals, Llc |
Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
|
US7056894B2
(en)
|
2001-01-04 |
2006-06-06 |
Albert Einstein College Of Medicine Of Yeshiva University |
Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof
|
SE0100158D0
(sv)
|
2001-01-19 |
2001-01-19 |
Synphora Ab |
Novel method and composition for local treatment of Meniere´s disease and tinnitus
|
WO2002060386A2
(en)
|
2001-02-01 |
2002-08-08 |
Bristol-Myers Squibb Company |
METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK)
|
FR2823441B1
(fr)
*
|
2001-04-12 |
2004-09-10 |
Thea Lab |
Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
|
US20030045515A1
(en)
|
2001-05-24 |
2003-03-06 |
Lise Binderup |
Combination medicament for treatment of neoplastic diseases
|
WO2002094265A1
(en)
|
2001-05-24 |
2002-11-28 |
Leo Pharma A/S |
A method of modulating nf-$g(k)b activity
|
SE0102617D0
(sv)
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
MXPA04002682A
(es)
|
2001-09-19 |
2004-06-18 |
Pharmacia Corp |
Compuestos pirazolilo sustituidos para el tratamiento de la inflamacion.
|
AU2002341729A1
(en)
|
2001-09-19 |
2003-04-01 |
Pharmacia Corporation |
Substituted pyrazolyl compounds for the treatment of inflammation
|
EP1448545B1
(en)
|
2001-10-04 |
2008-11-19 |
Smithkline Beecham Corporation |
Nf-kb inhibitors
|
AU2002356992A1
(en)
|
2001-11-21 |
2003-06-10 |
Albert Einstein College Of Medicine Of Yeshiva University |
Sir2 products and activities
|
PL373484A1
(en)
|
2001-12-10 |
2005-09-05 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
RS63204A
(en)
|
2002-01-17 |
2006-10-27 |
Neurogen Corporation |
Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
|
JP2003277383A
(ja)
|
2002-03-14 |
2003-10-02 |
Bayer Ag |
光学活性ピリジン誘導体およびそれを含む医薬
|
US7098334B2
(en)
|
2002-03-25 |
2006-08-29 |
Industrial Research Limited |
4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
|
DE60335635D1
(de)
|
2002-05-22 |
2011-02-17 |
Amgen Inc |
Aminopyrimidin-derivate zur verwendung als vanilloid-rezeptor-liganden zur behandlung von schmerzen
|
US7022680B2
(en)
|
2002-05-30 |
2006-04-04 |
Albert Einstein College Of Medicine Of Yeshiva University |
Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases
|
FR2841243B1
(fr)
*
|
2002-06-19 |
2004-08-20 |
Servier Lab |
Nouveaux derives de 3-(4-oxo-4h-chromen-2yl)-(1h)-quinolein- 4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
MXPA05001456A
(es)
|
2002-08-08 |
2005-06-06 |
Amgen Inc |
Ligandos del receptor vanilloide y su uso en tratamientos.
|
US7220431B2
(en)
|
2002-11-27 |
2007-05-22 |
Regents Of The University Of Minnesota |
Methods and compositions for applying pharmacologic agents to the ear
|
US7582635B2
(en)
|
2002-12-24 |
2009-09-01 |
Purdue Pharma, L.P. |
Therapeutic agents useful for treating pain
|
US20040185047A1
(en)
|
2003-03-21 |
2004-09-23 |
Jill Giles-Komar |
Anti- TNF antibodies, compositions, methods and uses
|
ATE457308T1
(de)
|
2003-04-21 |
2010-02-15 |
Lilly Co Eli |
Substituierte benzopyrane als selektive antagonisten am östrogenrezeptor-beta
|
US20040247575A1
(en)
|
2003-06-03 |
2004-12-09 |
Caplice Noel M. |
Smooth muscle progenitor cells
|
US7329664B2
(en)
|
2003-07-16 |
2008-02-12 |
Neurogen Corporation |
Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues
|
PL1648878T3
(pl)
|
2003-07-24 |
2009-10-30 |
Euro Celtique Sa |
Związki piperydynowe i zawierające je kompozycje farmaceutyczne
|
WO2005033105A2
(en)
|
2003-09-30 |
2005-04-14 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
BRPI0417270A
(pt)
|
2003-12-23 |
2007-03-27 |
Rinat Neuroscience Corp |
anticorpos agonistas antitrkc e métodos para utilização dos mesmos
|
TW200530235A
(en)
|
2003-12-24 |
2005-09-16 |
Renovis Inc |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
US7312330B2
(en)
|
2003-12-24 |
2007-12-25 |
Renovis, Inc. |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
US8268866B2
(en)
|
2004-03-29 |
2012-09-18 |
Matthieu Guitton |
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
|
US20060063802A1
(en)
|
2004-03-29 |
2006-03-23 |
Matthieu Guitton |
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
|
EP1747215A1
(en)
|
2004-05-12 |
2007-01-31 |
Aventis Pharmaceuticals, Inc. |
Substantially pure 2-{¬2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl|-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an ikb kinase inhibitor
|
CA2568028A1
(en)
|
2004-05-24 |
2005-12-08 |
Auris Medical, Llc. |
Combined otic aspirator and medication dispenser
|
US8498681B2
(en)
|
2004-10-05 |
2013-07-30 |
Tomophase Corporation |
Cross-sectional mapping of spectral absorbance features
|
US20060105967A1
(en)
|
2004-11-18 |
2006-05-18 |
Advanced Gene Technology, Corp. |
Flavone derivatives as TNFalpha inhibitors or antagonists
|
DE102005055385A1
(de)
*
|
2004-12-09 |
2006-06-14 |
Bayer Healthcare Ag |
Arzneimittel zur hygienischen Applikation im Ohr
|
WO2006061155A2
(de)
*
|
2004-12-09 |
2006-06-15 |
Bayer Healthcare Ag |
Stabilisierung von glucocorticoidestern mit säuren
|
UA88663C2
(en)
*
|
2004-12-09 |
2009-11-10 |
Баер Энимал Хелс Гмбх |
Stabilisation of glucocorticoid esters with acids
|
AR053114A1
(es)
|
2005-01-12 |
2007-04-25 |
Aventis Pharma Inc |
Sal monopotasica del acido 2-{[2-(-2-metilamino-pirimidin-4-il)-1h-indol-5-carbonil]-amino}-3-(fenilpiridin-2-il-amino)-propionico,inhibidora de ikk-2 quinasa
|
CA2595159A1
(en)
|
2005-01-13 |
2006-07-20 |
Sirtris Pharmaceuticals, Inc. |
Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
|
CA2593482A1
(en)
|
2005-01-14 |
2006-07-20 |
Neurogen Corporation |
Heteroaryl substituted quinolin-4-ylamine analogues
|
AU2006208042A1
(en)
|
2005-01-25 |
2006-08-03 |
Neurogen Corporation |
Substituted pyridazinyl-and pyrimidinyl-quinolin-4-ylamine analogues
|
US20060221197A1
(en)
|
2005-03-30 |
2006-10-05 |
Jung Edward K |
Image transformation estimator of an imaging device
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
EP2932971A1
(en)
*
|
2005-03-04 |
2015-10-21 |
Otonomy, Inc. |
Ketamine formulations
|
ES2331153T3
(es)
|
2005-03-10 |
2009-12-22 |
Pfizer Inc. |
Compuestos de n-sulfonilaminofeniletil-2-fenoxiacetamida sustituidos.
|
CA2601468A1
(en)
|
2005-03-14 |
2006-09-21 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
CN101160285A
(zh)
|
2005-03-17 |
2008-04-09 |
辉瑞大药厂 |
适用于治疗疼痛的n-(n-磺酰氨基甲基)环丙烷甲酰胺衍生物
|
EP1893583B1
(en)
|
2005-05-31 |
2012-04-04 |
Pfizer Inc. |
Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
|
US7785834B2
(en)
|
2005-11-10 |
2010-08-31 |
Ercole Biotech, Inc. |
Soluble TNF receptors and their use in treatment of disease
|
US20070219272A1
(en)
|
2006-02-06 |
2007-09-20 |
Johan Stjernschantz |
Novel method and compositions for treatment of tinnitus
|
US7760617B2
(en)
|
2006-03-24 |
2010-07-20 |
Lg Electronics Inc. |
Method and structure of configuring preamble to support transmission of data symbol in a wireless communication system
|
US7744746B2
(en)
|
2006-03-31 |
2010-06-29 |
Exxonmobil Research And Engineering Company |
FCC catalyst stripper configuration
|
CN103349659A
(zh)
*
|
2006-09-26 |
2013-10-16 |
塔罗制药北美有限公司 |
液体药物组合物以及应用
|
US8377898B2
(en)
|
2006-10-12 |
2013-02-19 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
|
BRPI0720473A2
(pt)
|
2006-12-20 |
2014-01-14 |
Rinat Neuroscience Corp |
Agonistas de trkb para tratamento de distúbios autoimunes
|
EP2254572B1
(en)
|
2008-02-07 |
2013-10-16 |
Massachusetts Eye & Ear Infirmary |
Compounds that enhance atoh-1 expression
|
EP2278999A4
(en)
*
|
2008-04-21 |
2015-04-22 |
Otonomy Inc |
EARLY TREATMENT FORMULATIONS FOR THE TREATMENT OF EARLY DISEASES AND DRESSES
|
US9200080B2
(en)
|
2010-09-03 |
2015-12-01 |
Horacio Uri Saragovi |
Agonistic antibodies to TrkC receptors and uses thereof
|
US9125894B2
(en)
|
2010-10-06 |
2015-09-08 |
Massachusetts Eye & Ear Infirmary |
Methods for promoting reinnervation of auditory hair cells
|
EP2667881A4
(en)
|
2011-01-24 |
2015-04-22 |
Univ Leland Stanford Junior |
METHODS OF GENERATING IN VITRO INTERNAL EAR CELLS
|
EP2765992A4
(en)
*
|
2011-10-10 |
2015-04-08 |
Otic Pharma Ltd |
FOAM FORMULATIONS
|
DE202012100195U1
(de)
|
2012-01-19 |
2012-03-01 |
Nordmark Arzneimittel Gmbh & Co. Kg |
Neue Verwendung einer pharmazeutischen Zusammensetzung, enthaltend Ancrod
|
JP2015511242A
(ja)
|
2012-02-23 |
2015-04-16 |
インセルム(インスティチュート ナショナル デ ラ サンテ エ デ ラリシェルシェ メディカル) |
病変性前庭障害の治療に使用するカルシニューリン阻害剤
|
WO2013173803A2
(en)
*
|
2012-05-17 |
2013-11-21 |
Michael Spector |
Formulations of amoxicillin and clavulanate potassium and methods for using same
|
JP2015521194A
(ja)
|
2012-05-30 |
2015-07-27 |
センソリオン |
前庭毒性を処置するための方法
|
US9688989B2
(en)
|
2012-06-08 |
2017-06-27 |
Sensorion |
H4 receptor inhibitors for treating tinnitus
|
WO2014039781A1
(en)
|
2012-09-07 |
2014-03-13 |
Massachusetts Eye & Ear Infirmary |
Treating hearing loss
|
EP2853533A1
(de)
|
2013-09-29 |
2015-04-01 |
Audiocure Pharma GmbH |
6-Fluor-9-methyl-ß-carbolin
|
US10603295B2
(en)
|
2014-04-28 |
2020-03-31 |
Massachusetts Eye And Ear Infirmary |
Sensorineural hair cell differentiation
|
JP2017522360A
(ja)
*
|
2014-07-29 |
2017-08-10 |
オトノミー,インク. |
耳垢症の処置のための耳科用製剤
|
FR3024361B1
(fr)
|
2014-07-30 |
2017-11-24 |
Affichem |
Utilisation de derives de sterols pour traitement de la perte auditive neurosensorielle et composition correspondante
|
EP2982382A1
(en)
|
2014-08-04 |
2016-02-10 |
Sensorion |
Compounds for preventing ototoxicity
|
US20170314027A1
(en)
|
2014-08-06 |
2017-11-02 |
Massachusetts Eye And Ear Infirmary |
Increasing atoh1 life to drive sensorineural hair cell differentiantion
|
DE202015100655U1
(de)
*
|
2015-02-03 |
2016-02-04 |
Bio.Lo.Ga. S.R.L. |
Pharmazeutische Zusammensetzung zur topischen Anwendung im Gehörgang
|
SG11201706316PA
(en)
|
2015-02-11 |
2017-09-28 |
Support-Venture Gmbh |
Method of preventing or treating hearing loss
|
TWI625332B
(zh)
|
2015-07-07 |
2018-06-01 |
美國禮來大藥廠 |
刻痕(notch)路徑傳訊抑制化合物
|